PT  - JOURNAL ARTICLE
AU  - Charles A Dinarello
TI  - Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment.
DP  - 2005 Mar 01
TA  - The Journal of Rheumatology
PG  - 40--47
VI  - 74
4099  - http://www.jrheum.org/content/74/40.short
4100  - http://www.jrheum.org/content/74/40.full
SO  - J Rheumatol2005 Mar 01; 74
AB  - This review examines the differences in the incidence, spectrum, and mechanisms of activation of opportunistic infections, such as Mycobacterium tuberculosis, in patients with rheumatic diseases treated with the soluble TNF p75 receptor etanercept compared to the 2 anti-TNF-alpha monoclonal antibodies, infliximab and adalimumab.